25 /100
LOW RISK
Score updated May 30, 2026

SLS — SELLAS Life Sciences Group, Inc. Dilution Risk Tracker

Track SLS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SLS — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
17
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for SLS.
🔔 Track SLS — Get forecast alerts →

💹 Market Data

Market Cap$1.73B
Shares Outstanding186.03M
Float185.23M
Cash$107.10M
Debt$871.0K
Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 41.02M shares
#1 Blackrock Inc. 12.20M shares
#2 State Street Corporation 8.40M shares
#3 Vanguard Capital Management LLC 7.53M shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest57.07M
Days to Cover7.1
% of Float30.8%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2017
13F-HR BENEFICIAL OWNERSHIP Mar 31, 2026
13F-HR BENEFICIAL OWNERSHIP Mar 31, 2026
13F-HR BENEFICIAL OWNERSHIP Mar 31, 2026
Full SEC filing analysis available with free account

📰 Recent News

Track SLS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SLS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for SLS
📊 SLS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 SLS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.